Literature DB >> 16214093

Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18.

Nicola Calvani1, Marco Tucci, Hanno B Richards, Paola Tartaglia, Franco Silvestris.   

Abstract

Excessive T helper cell function is a hallmark of systemic lupus erythematosus and abnormalities of T helper cytokine profiles have been implicated in loss of immune tolerance, increased antigenic load, defective B cell suppression and a variety of clinical manifestations. Here, we emphasize the importance of T helper 1-type (i.e., IFN-gamma) with respect to T helper 2-type (i.e., IL-4) cytokines in promoting the pathogenesis of lupus nephritis focusing on the critical role of IL-18, a major T helper 1 differentiation factor. IL-18 is overexpressed in patients with lupus nephritis along with higher INF-gammaand lower IL-4 production as compared to non-nephritic lupus patients. We hypothesize a pathogenic model where both the onset and aggravation of nephritis are promoted by an imbalance of immune response towards a T helper 1 cytokine predominance due to IL-18 up-regulation. In contrast, a T helper 2-skewed cytokine profile may possibly prevent the development of renal disease. In this context, IL-18 represents a novel marker of lupus nephritis and its measurement may be helpful in the assessment of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214093     DOI: 10.1016/j.autrev.2005.04.009

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  28 in total

Review 1.  Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?

Authors:  B Hervier; M Hamidou; J Haroche; C Durant; A Mathian; Z Amoura
Journal:  Rheumatol Int       Date:  2011-07-30       Impact factor: 2.631

Review 2.  Inflammasomes and autoimmunity.

Authors:  Patrick J Shaw; Michael F McDermott; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2010-12-14       Impact factor: 11.951

3.  MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity.

Authors:  Thomas X Lu; Jochen Hartner; Eun-Jin Lim; Victoria Fabry; Melissa K Mingler; Eric T Cole; Stuart H Orkin; Bruce J Aronow; Marc E Rothenberg
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

4.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

Review 5.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

6.  Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus.

Authors:  Lijun Song; Feng Qiu; Yuchen Fan; Feng Ding; Huaxiang Liu; Qiang Shu; Weiwei Liu; Xingfu Li
Journal:  J Clin Immunol       Date:  2012-09-09       Impact factor: 8.317

7.  Association of IL-18 gene polymorphism (-137C) with arthritis manifestations in SLE: combined effect with IFN gamma gene polymorphism (+874A).

Authors:  Nattiya Hirankarn; Marut Tangwattanachuleeporn; Jongkonnee Wongpiyabovorn; Jeerapat Wongchinsri; Yingyos Avihingsanon
Journal:  Clin Rheumatol       Date:  2008-11-25       Impact factor: 2.980

8.  Elevated Interleukin-18 Receptor Accessory Protein Mediates Enhancement in Reactive Oxygen Species Production in Neutrophils of Systemic Lupus Erythematosus Patients.

Authors:  Jie Ma; Ian Kar Yin Lam; Chak-Sing Lau; Vera Sau Fong Chan
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

Review 9.  Protective and detrimental roles of inflammasomes in disease.

Authors:  Pedro H V Saavedra; Dieter Demon; Hanne Van Gorp; Mohamed Lamkanfi
Journal:  Semin Immunopathol       Date:  2015-04-21       Impact factor: 11.759

10.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.